About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Profit & Loss
Neuland Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:
524558
NSE Symbol:
NEULANDLAB
P/E :
85.96
ISIN Demat:
INE794A01010
Div & Yield %:
0.09
EPS :
161.75
Book Value:
1,182.30
Market Cap (Rs. Cr.):
17,839.26
Face Value :
10
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
1,476.84
1,558.58
1,191.20
951.08
936.91
762.71
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,476.84
1,558.58
1,191.20
951.08
936.91
762.71
Other Income
96.91
12.54
9.75
2.08
16.09
3.89
Stock Adjustments
-12.83
55.14
9.51
15.41
1.24
11.16
Total Income
1,560.92
1,626.26
1,210.46
968.57
954.24
777.76
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
578.45
636.49
491.98
441.79
443.04
394.41
Power & Fuel Cost
50.56
48.72
48.62
42.21
39.21
32.75
Employee Cost
261.40
248.53
194.84
175.76
144.02
118.48
Other Manufacturing Expenses
108.66
103.73
82.69
84.92
73.71
61.79
Selling & Administrative Expenses
120.52
104.29
88.50
70.50
79.80
51.76
Miscellaneous Expenses
22.11
10.04
22.77
9.12
11.93
13.21
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,141.71
1,151.81
929.40
824.29
791.71
672.41
Operating Profit
419.22
474.47
281.06
144.27
162.54
105.34
Interest
8.30
14.00
13.07
13.49
17.90
21.57
Gross Profit
410.92
460.47
267.99
130.78
144.64
83.77
Depreciation
65.54
59.70
52.78
49.04
39.68
31.28
Profit Before Tax
345.38
400.77
215.21
81.74
104.96
52.49
Tax
73.65
99.59
50.39
20.42
12.48
0.00
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
12.29
1.59
1.70
-2.22
12.18
36.62
Reported Net Profit
259.43
299.60
163.12
63.53
80.29
15.88
Extraordinary Items
51.90
-0.30
-0.66
-1.36
9.81
0.12
Adjusted Net Profit
207.53
299.90
163.78
64.89
70.48
15.76
Adjustment below Net Profit
0.00
0.00
0.00
0.00
0.00
-0.18
P & L Balance brought forward
747.31
460.54
303.84
244.15
166.42
155.67
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
17.96
12.83
6.41
3.85
2.57
4.95
P & L Balance carried down
988.77
747.31
460.54
303.84
244.15
166.42
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
120.00
140.00
100.00
50.00
50.00
20.00
Dividend Per Share(Rs)
12.00
14.00
10.00
5.00
5.00
2.00
Earnings Per Share-Unit Curr
201.10
232.24
126.44
49.25
62.24
12.31
Earnings Per Share(Adj)-Unit Curr
201.10
232.24
126.44
49.25
62.24
12.31
Book Value-Unit Curr
1,175.89
988.88
765.49
647.06
605.44
546.26
Book Value(Adj)-Unit Curr
1,175.89
988.88
765.49
647.06
605.44
546.26